This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1996 Feb;14(2):687-8.

doi: 10.1200/JCO.1996.14.2.687.

Cost-effectiveness: let's get "real"

PMID: 8636797
DOI: 10.1200/JCO.1996.14.2.687

Comment

Cost-effectiveness: let's get "real"

S R Lemkin. J Clin Oncol. 1996 Feb.

. 1996 Feb;14(2):687-8.

doi: 10.1200/JCO.1996.14.2.687.

Author

PMID: 8636797
DOI: 10.1200/JCO.1996.14.2.687

No abstract available

PubMed Disclaimer

Comment on

Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer.
Smith TJ, Hillner BE, Neighbors DM, McSorley PA, Le Chevalier T. Smith TJ, et al. J Clin Oncol. 1995 Sep;13(9):2166-73. doi: 10.1200/JCO.1995.13.9.2166. J Clin Oncol. 1995. PMID: 7666075 Clinical Trial.
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
Le Chevalier T, Brisgand D, Douillard JY, Pujol JL, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, et al. Le Chevalier T, et al. J Clin Oncol. 1994 Feb;12(2):360-7. doi: 10.1200/JCO.1994.12.2.360. J Clin Oncol. 1994. PMID: 8113844 Clinical Trial.

Similar articles

News from "the real world": cost-effectiveness in palliative care.
[No authors listed] [No authors listed] Support Care Cancer. 1994 Jul;2(4):211-2. Support Care Cancer. 1994. PMID: 7522105 No abstract available.
Let's focus on the real issues.
Eidelman SM, Pietrangelo R, Gardner JF, Jesien G, Croser MD. Eidelman SM, et al. Ment Retard. 2003 Apr;41(2):126-9. doi: 10.1352/0047-6765(2003)041<0126:LSFOTR>2.0.CO;2. Ment Retard. 2003. PMID: 12622528 No abstract available.
Let's get personal.
Morrison J. Morrison J. Ment Health Today. 2010 Feb:10-2. Ment Health Today. 2010. PMID: 20201140 No abstract available.
[Innovations with system disrupting potential? New drugs of high value].
Pfannkuche MS, Glaeske G. Pfannkuche MS, et al. Pharm Unserer Zeit. 2008;37(5):416-22. doi: 10.1002/pauz.200800282. Pharm Unserer Zeit. 2008. PMID: 18729265 Review. German. No abstract available.
Decision analysis and cost-effectiveness analysis for comparative effectiveness research--a primer.
Sher DJ, Punglia RS. Sher DJ, et al. Semin Radiat Oncol. 2014 Jan;24(1):14-24. doi: 10.1016/j.semradonc.2013.08.002. Semin Radiat Oncol. 2014. PMID: 24314338 Review.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.